MedPath

STUDY TO SEE THE EFFECT OF ERECTOR SPINAE PLANE BLOCK AND QUADRATUS LUMBORUM BLOCK FOR PAIN RELEIF IN PATIENTS UNDERGOING RENAL TRANSPLANT OPERATION

Phase 2
Not yet recruiting
Conditions
End stage renal disease,
Registration Number
CTRI/2019/09/021219
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

This study is a randomised single blinded study to compare perioperative analgesic efficacy of Erector spinae plane block and Quadratus lumborum block in patients undergoing renal transplantation

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Patients undergoing renal transplantation under General Anesthesia.

Exclusion Criteria
  • Patient refusal to participate 2.
  • Known hypersensitivity to local anaesthetic drug 3.
  • Patient having infection at site of block 4.
  • Patient having spinal Deformity and previous history 5.
  • Patients on anti coagulants 6.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compare perioperative fentanyl consumption between Erector spinae plane block group, Quadratus lumborum block group and control group in patients undergoing renal transplantation over a period of 24 hours after surgeryIntraoperative time plus postoperative follow up of 24 hours
Secondary Outcome Measures
NameTimeMethod
Pain scores using numerical rating scale, time for first rescue analgesic and incidence of postoperative nausea and vomiting between Erector spinae plane block group, Quadratus lumborum block group and control group in patients undergoing renal transplantation surgery over a period of 24 hoursIntraoperative time plus postoperative follow up of 24 hours

Trial Locations

Locations (1)

All India Institute of Medical Sciences

🇮🇳

Delhi, DELHI, India

All India Institute of Medical Sciences
🇮🇳Delhi, DELHI, India
Dr Gudela Mohan Sai
Principal investigator
9599086268
gudelamohansai.007@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.